Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06382168
Status:
RECRUITING
Last Update Posted:
2024-04-24
First Post:
2024-04-19
Brief Title:
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
Sponsor:
Delta-Fly Pharma Inc
Organization:
Delta-Fly Pharma Inc
Organization Data
Organization:
Delta-Fly Pharma Inc
Class:
INDUSTRY
Study ID:
D19-11186
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Delta-Fly Pharma Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None